Rethinking Sedation/Canine Lymphoma #23065

Actions Panel

Rethinking Sedation/Canine Lymphoma #23065

"Zennovation in Sedation..." and "Verdinexor: A Novel Oral Therapy for Canine Lymphoma" presented by Kathy Engler, DVM, DABVP

By Dechra Veterinary Products

Date and time

Starts on Thursday, February 23, 2023 · 7pm AKST

Location

Simon & Seafort's

420 L Street Anchorage, AK 99501

About this event

Speaker: Kathy Engler, DVM, DABVP

Topic: "Zennovation in Sedation: Rethinking What is Possible" and "Verdinexor: A Novel Oral Therapy for Canine Lymphoma"

In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides). Part 2: This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.

Dinner Meeting

Simon & Seafort's

420 L Street

Anchorage, AK 99501

907-274-3502

Thursday, February 23, 2023

Check-In: 6:30 PM - 7:00 PM, Alaskan

Presentation: 7:00 PM - 9:00 PM, Alaskan

Register by: Wednesday, February 22, 2023

CE Credits: 2

Contact(s):

Mike Blackburn, Territory Manager

206-321-6400

Mike.Blackburn@dechra.com

Additional Notes: Veterinarians, Technicians, and Practice Managers are invited.

Organized by

Cancelled